There are several Pompe Disease Therapeutic options available for managing Pompe disease, including enzyme replacement therapy, substrate reduction therapy, gene therapy, and physical therapy and rehabilitation. While there is currently no cure for Pompe disease, these therapies can help to manage the symptoms and slow the progression of the disease. It is important for patients with Pompe disease to work closely with their healthcare team to develop a treatment plan that meets their individual needs and goals.
The ailment known as Pompe Disease Therapeutic, sometimes referred to as glycogen storage disease type II (GSD2), is brought on by mutations in the GAA gene, which codes for the production of the enzyme known as acid alpha-glucosidase or GAA. This enzyme is required to degrade the intricate sugar molecule known as glycogen. The symptoms of Pompe disease are caused by the GAA enzyme's dysfunction, which leads to a toxic accumulation of glycogen in the body's cells, particularly muscle cells. By treating the underlying cause of Pompe illness, ERT aims to delay its progression. Additionally, a variety of additional supportive measures can aid Pompe patients in maximising their capacity to carry out daily activities. The majority of medicines used to treat Pompe illness are long-term.
Source Link- https://cmiblogdailydose.blogspot.com/2023/02/pompe-disease-therapeutic-is-used-to.html
